These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31081687)

  • 1. microRNAs: Novel Markers in Diagnostics and Therapeutics of Celiac Disease.
    Chamani E; Sargolzaei J; Tavakoli T; Rezaei Z
    DNA Cell Biol; 2019 Jul; 38(7):708-717. PubMed ID: 31081687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
    de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
    J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
    Costantini S; Rossi M; Colonna G; Facchiano AM
    J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathomechanisms in celiac disease.
    Dieterich W; Esslinger B; Schuppan D
    Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Human Leukocyte Antigen in Celiac Disease Diagnostics.
    Lázár-Molnár E; Snyder M
    Clin Lab Med; 2018 Dec; 38(4):655-668. PubMed ID: 30420059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
    Bodd M; Kim CY; Lundin KE; Sollid LM
    Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules.
    Bergseng E; Sidney J; Sette A; Sollid LM
    Hum Immunol; 2008 Feb; 69(2):94-100. PubMed ID: 18361933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
    Schuppan D; Dennis MD; Kelly CP
    Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of celiac disease in daily clinical practice.
    Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
    Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
    Koning F; Gilissen L; Wijmenga C
    Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice.
    Mazzarella G; Bergamo P; Maurano F; Luongo D; Rotondi Aufiero V; Bozzella G; Palmieri G; Troncone R; Auricchio S; David C; Rossi M
    Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G302-12. PubMed ID: 24924747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQ2.5 genes associated with celiac disease risk are preferentially expressed with respect to non-predisposing HLA genes: Implication for anti-gluten T cell response.
    Pisapia L; Camarca A; Picascia S; Bassi V; Barba P; Del Pozzo G; Gianfrani C
    J Autoimmun; 2016 Jun; 70():63-72. PubMed ID: 27083396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
    Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DQ2/DQ8 and HLA-DQB1*02 homozygosity typing by real-time polymerase chain reaction for the assessment of celiac disease genetic risk: evaluation of a Spanish celiac population.
    Ruiz-Ortiz E; Montraveta M; Cabré E; Herrero-Mata MJ; Pujol-Borrell R; Palou E; Faner R
    Tissue Antigens; 2014 Dec; 84(6):545-53. PubMed ID: 25413104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of celiac disease.
    Koning F
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S1-4. PubMed ID: 24979191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localization of gluten consumption and HLA-DQ2 and -DQ8 genotypes, a clue to the history of celiac disease.
    Lionetti E; Catassi C
    Dig Liver Dis; 2014 Dec; 46(12):1057-63. PubMed ID: 25200477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen DQ2.2 and celiac disease.
    Mubarak A; Spierings E; Wolters V; van Hoogstraten I; Kneepkens CM; Houwen R
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):428-30. PubMed ID: 23085892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.
    Vader W; Stepniak D; Kooy Y; Mearin L; Thompson A; van Rood JJ; Spaenij L; Koning F
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12390-5. PubMed ID: 14530392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.